OPPORTUNITY™: A Randomized Clinical Trial of Growth Hormone on Outcome in Hemodialysis Patients

Background: The mortality rate of maintenance hemodialysis (MHD) patients remains high. Measures of protein-energy wasting, including hypoalbuminemia, are strongly associated with their high mortality. Growth hormone (GH) may improve lean body mass (LBM) and serum albumin levels, and health-related...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kopple, Joel D., Cheung, Alfred K., Christiansen, Jens Sandahl, Djurhuus, Christian Born, El Nahas, Meguid, Feldt-Rasmussen, Bo, Lange, Martin, Mitch, William E., Wanner, Christoph, Wiedemann, Jonas, Ikizler, T. Alp
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Nephrology 2008
Gaiak:
Dialysis
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2572295/
https://ncbi.nlm.nih.gov/pubmed/18945992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.02760608
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak